2nd Taiwanese COVID-19 vaccine maker applies for EUA

Taiwanese company United Biomedical Inc. (UBI) Asia on Wednesday applied for emergency use authorization (EUA) in Taiwan for its COVID-19 vaccine candidate, after releasing the interim results of its Phase 2 clinical trials last weekend, according to its subsidiary.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)